Common Contracts
11 similar Severance Agreement contracts by Aeglea BioTherapeutics, Inc., Proterra Inc, ArcLight Clean Transition Corp.
SEVERANCE AGREEMENTSeverance Agreement • August 9th, 2023 • Proterra Inc • Motor vehicles & passenger car bodies • California
This Severance Agreement (the “Agreement”) is entered into as of 5/8/2023 (the “Effective Date”) by and between David Scott Black (the “Executive”) and Proterra Inc, a Delaware corporation (the “Company”).
SEVERANCE AGREEMENTSeverance Agreement • August 9th, 2023 • Proterra Inc • Motor vehicles & passenger car bodies • California
This Severance Agreement (the “Agreement”) is entered into as of 6/8/2023 (the “Effective Date”) by and between Jeffrey Donald Embt (the “Executive”) and Proterra Inc, a Delaware corporation (the “Company”).
SEVERANCE AGREEMENTSeverance Agreement • March 17th, 2023 • Proterra Inc • Motor vehicles & passenger car bodies • California
This Severance Agreement (the “Agreement”) is entered into as of (the “Effective Date”) by and between [ ] (the “Executive”) and Proterra Inc, a Delaware corporation (the “Company”).
SEVERANCE AGREEMENTSeverance Agreement • March 14th, 2022 • Proterra Inc • Motor vehicles & passenger car bodies • California
This Severance Agreement (the “Agreement”) is entered into as of September 11, 2018 (the “Effective Date”) by and between Josh Ensign (the “Executive”) and Proterra Inc, a Delaware corporation (the “Company”).
SEVERANCE AGREEMENTSeverance Agreement • March 14th, 2022 • Proterra Inc • Motor vehicles & passenger car bodies • California
This Severance Agreement (the “Agreement”) is entered into as January 1, 2022 (the “Effective Date”) by and between Gareth T. Joyce (the “Executive”) and Proterra Inc, a Delaware corporation (the “Company”).
SEVERANCE AGREEMENTSeverance Agreement • March 8th, 2022 • Aeglea BioTherapeutics, Inc. • Pharmaceutical preparations • Texas
This Severance Agreement (the “Agreement”) is entered into as of July 6, 2021 (the “Effective Date”) by and between Jonathan Alspaugh (the “Executive”) and Aeglea BioTherapeutics, Inc., a Delaware corporation (the “Company”).
SEVERANCE AGREEMENTSeverance Agreement • April 7th, 2021 • ArcLight Clean Transition Corp. • Motor vehicles & passenger car bodies • California
This Severance Agreement (the “Agreement”) is entered into as of [DATE] (the “Effective Date”) by and between [NAME] (the “Executive”) and Proterra Inc, a Delaware corporation (the “Company”).
SEVERANCE AGREEMENTSeverance Agreement • May 7th, 2020 • Aeglea BioTherapeutics, Inc. • Pharmaceutical preparations • Texas
This Severance Agreement (the “Agreement”) is entered into as of August 7, 2019 (the “Effective Date”) by and between Leslie Sloan, Ph.D. (the “Executive”) and Aeglea BioTherapeutics, Inc., a Delaware corporation (the “Company”).
SEVERANCE AGREEMENTSeverance Agreement • July 23rd, 2018 • Aeglea BioTherapeutics, Inc. • Pharmaceutical preparations • Texas
This Severance Agreement (the “Agreement”) is entered into as of July 18, 2018 (the “Effective Date”) by and between Anthony Quinn (the “Executive”) and Aeglea BioTherapeutics, Inc., a Delaware corporation (the “Company”).
SEVERANCE AGREEMENTSeverance Agreement • April 16th, 2018 • Aeglea BioTherapeutics, Inc. • Pharmaceutical preparations • Texas
This Severance Agreement (the “Agreement”) is entered into as of April __, 2018 (the “Effective Date”) by and between __________________ (the “Executive”) and Aeglea BioTherapeutics, Inc., a Delaware corporation (the “Company”).
Vice President of Finance Severance AgreementSeverance Agreement • March 23rd, 2017 • Aeglea BioTherapeutics, Inc. • Pharmaceutical preparations • Texas
This Vice President of Finance Severance Agreement (the “Agreement”) is entered into as of July 7, 2015 (the “Effective Date”) by and between Charles N. York II (the “Executive”) and Aeglea BioTherapeutics, Inc., a Delaware corporation (the “Company”).
